Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: Gurupup who wrote (3860)	7/1/1998 7:02:00 PM
From: Ron Harvey	Read Replies (1) \| Respond to of 5736

<<Try to figure out the risk reward from current levels. Maybe $ 1/2 down, and maybe $4-5 up.>> This is what I've been wrestling with to try to determine whether CCSI is worth another bet or not before a distribution partnership is announced. Even if you don't go along with what I'm going to posit, respond to it as a hypothetical instance. Suppose, as I expect, the deal provides Chromatics with a not uncommon 8% licensing fee (the CEO reluctantly settling for this after conceding she's not going to get the generous arrangement she'd been hoping for). Maybe even as high as 10%, although that could be iffy. Under these (hypothetical) circumstances, what might be the financial implications to the company for the first year out should the medical-device product receive acceptance by pediatricians and hospitals? Conservative estimates, of course.